Latest filing published 09 Sept 2021 for Tvardi Therapeutics, Inc., €261k.
Filing timeline
BuySaleInsider track record
Derek T. Chalmers: trading record in brief
Derek T. Chalmers is a declared insider of Tvardi Therapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). Between 5 February 2014 and 7 September 2021, the trades on record add up to 58 filings.
Every open-market trade on record is a sale: 42 sales worth €6.3M. Outside the open market, there are 10 share grants and 4 option exercises. Since January 2021: no purchases and 4 sales on the market.
The newest entry dates from 9 September 2021: an open-market sale of €261k, in Tvardi Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Derek T. Chalmers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$15.4772.0% of flowCommon StockSEC:0001209191-21-055304:0
- 8,440 shares@ US$14.2028.0% of flowCommon StockSEC:0001209191-21-054300:0
- 17,334 shares0Common StockSEC:0001209191-21-053534:0
- 52,000 shares0Common StockSEC:0001209191-21-024294:0
- 3,103 shares@ US$17.980.9% of flowCommon StockSEC:0001209191-21-018644:1
- 10,000 shares0Common StockSEC:0001209191-21-018644:0
- 11,729 shares@ US$19.333.6% of flowCommon StockSEC:0001209191-21-014547:1
- 18,750 shares0Common StockSEC:0001209191-21-014547:0
- 6,078 shares@ US$15.304.6% of flowCommon StockSEC:0001209191-20-065578:0
- 5,000 shares@ US$16.003.9% of flowCommon StockSEC:0001209191-20-065406:1
- 18,750 shares0Common StockSEC:0001209191-20-065406:0
- 5,000 shares@ US$14.953.7% of flowCommon StockSEC:0001209191-20-064450:0
- 7,500 shares@ US$15.295.7% of flowCommon StockSEC:0001209191-20-063097:0
- 11,799 shares@ US$16.009.6% of flowCommon StockSEC:0001209191-20-059475:0
- 3,201 shares@ US$16.002.4% of flowCommon StockSEC:0001209191-20-049749:0
- 5,000 shares@ US$16.423.8% of flowCommon StockSEC:0001209191-20-045254:0
- 5,000 shares@ US$17.113.8% of flowCommon StockSEC:0001209191-20-040373:0
- 700 shares@ US$16.000.5% of flowCommon StockSEC:0001209191-20-034314:0
- 4,300 shares@ US$16.013.1% of flowCommon StockSEC:0001209191-20-034314:1
- 1,200 shares@ US$16.000.9% of flowCommon StockSEC:0001209191-20-031860:0
- 3,500 shares@ US$16.002.6% of flowCommon StockSEC:0001209191-20-031860:1
- 371 shares@ US$16.000.3% of flowCommon StockSEC:0001209191-20-031860:2
- 4,929 shares@ US$16.003.6% of flowCommon StockSEC:0001209191-20-029397:0
- 6,348 shares@ US$15.564.6% of flowCommon StockSEC:0001209191-20-025306:1
- 20,000 shares0Common StockSEC:0001209191-20-025306:0
25 of 58 declarations